Shares of the alternative asset manager have retreated sharply from recent highs, prompting investors to question whether the stock's premium valuation remains justified. We examine the key metrics and what the pullback might signal.
As gold and silver surge to record highs, Bitcoin's recent slump reignites debate over its viability as a modern safe-haven asset, challenging its long-touted 'digital gold' narrative.
Bank of America has revised its price target for consumer goods giant Kimberly-Clark downward, citing sector-wide valuation pressures, even as the company reports resilient earnings and advances its transformation into a broader health and wellness player.
Omega Healthcare Investors (OHI) maintains its quarterly dividend, offering a signal of stability to income-focused shareholders as the healthcare REIT navigates tenant health and leverage concerns in a challenging operating environment.
While the consumer staples sector has lagged the broader market rally, select companies continue to demonstrate defensive strength and growth potential. We analyze one standout and two stocks facing significant headwinds.
The healthcare sector has surged 17.4% in six months, outpacing the S&P 500. While demographic trends fuel long-term growth, regulatory hurdles and valuation concerns demand selective investing. We analyze one company built for decades of returns and two where investors should tread carefully.
Shares of Monolithic Power Systems (MPWR) have soared over 230% in five years, but new analysis suggests the semiconductor leader's stock may now be trading at a significant premium. Investors are weighing whether the rally has outpaced fundamentals.
Sources indicate OpenAI is accelerating plans for a late-2026 public listing, a move that would place its massive cash burn and long road to profitability under intense investor scrutiny, potentially defining the next phase of the AI boom.
Shares of Cushman & Wakefield have surged 35.8% in six months, dramatically outpacing the broader market. While strong quarterly results fueled the climb, a deeper look at the firm's long-term financial health reveals potential headwinds that could give investors pause.
A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.
Netflix's unprecedented all-cash offer to acquire Warner Bros. Discovery has sent shockwaves through the media industry, setting the stage for a fierce regulatory battle and raising fundamental questions about the streaming giant's financial strategy and market dominance.
Paramount Skydance has appointed seasoned Capitol Hill and private sector strategist Ted Lehman as its top U.S. policy executive, a move signaling an intensified government relations focus as the media giant navigates a complex merger landscape and regulatory battles.
Karat Packaging Inc. (NASDAQ: KRT) showcases a consistent 18% return on capital employed, outperforming its industry. Yet, as capital investment grows, analysts debate whether the sustainable packaging firm can accelerate value creation for shareholders seeking multi-bagger potential.
Despite posting robust quarterly earnings, Microsoft shares tumbled over 10% as investors balked at rising costs and a cautious outlook, raising questions about the sustainability of its AI-driven growth narrative.
Deutsche Bank's 2025 net profit nearly doubled to €7.1bn, fueled by revenue gains and cost cuts across all divisions, even as German prosecutors launch a money-laundering investigation linked to the lender.
China Life Insurance announces governance changes and a major investment partnership, highlighting a strategic pivot towards long-term, related-party investments amidst evolving regulatory landscapes in Asia's insurance sector.
As the Bank of Canada holds rates steady, speculative capital is sifting through junior resource stocks. We examine three micro-caps—a driller, an explorer, and an oil hopeful—navigating unique challenges and opportunities in early 2026.
3D Energi's failure to meet a payment obligation on the ConocoPhillips-operated Otway Basin exploration project has triggered a trading halt and raised questions about cost impacts, partnership structures, and the oil major's valuation resilience.
Lam Research capitalizes on soaring demand for AI chipmaking equipment, reporting record quarterly and annual revenue. While the company is aggressively expanding capacity to address supply chain bottlenecks, some analysts question if its valuation already reflects the AI-driven growth.
AI cloud provider CoreWeave faces a critical juncture as a massive equity investment from chip giant Nvidia clashes with securities class actions alleging the company misled investors about its operational capacity and supplier dependencies.
